SCHEMBL2367455

SCHEMBL2367455

CC(C)(C)[C@]1(C(N)=O)CCCN1C(=O)O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.30
GRIN2C Q14957 1/20 0.30
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239129 1.00 GRIN2B (0.30) GRIN2BGRIN2CDPP4
SCHEMBL82277 0.95
SCHEMBL933448 0.84
SCHEMBL3190616 0.83
SCHEMBL1150703 0.83
SCHEMBL1150705 0.83
SCHEMBL17801011 0.81 DGAT1 (0.33)
SCHEMBL17259076 0.79 HSD11B1 (0.36)
SCHEMBL7438886 0.79 NPSR1 (0.33)
SCHEMBL15855789 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102482269-B Proline derivatives NATIONAL HEALTH RESEARCH INSTITUTES (CN) 2015-07-29 CN disclosed
EP-2692726-A1 Anti-viral compounds Abbvie Inc. (US) 2014-02-05 EP disclosed
CN-102482269-A Proline derivatives NAT HEALTH RESEARCH INSTITUTES 2012-05-30 CN disclosed
EP-2368890-A1 Hepatitis C virus inhibitors Abbott Laboratories (US) 2011-09-28 EP disclosed